Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility.
MacIsaac MB, Whitton B, Anderson J, Cogger S, Vella-Horne D, Penn M, Weeks T, Elmore K, Pemberton D, Winter RJ, Papaluca T, Howell J, Hellard M, Stoové M, Wilson D, Pedrana A, Doyle JS, Clark N, Holmes JA, Thompson AJ.
Hepatitis C Injecting Drug Use
Characterizing Socioecological Markers of Differentiated HIV Risk Among Men Who Have Sex with Men in Indonesia.
Nevendorff L, Pedrana A, Bourne A, Traeger M, Sindunata E, Reswana WA, Alharbi RM, Stoové M.
Hepatitis C
Effectiveness of care bundles for prevention and treatment of postpartum hemorrhage: a systematic review.
Vogel JP, Nguyen PY, Ramson J, De Silva MS, Pham MD, Sultana S, McDonald S, Adu-Bonsaffoh K, McDougall ARA.
Maternal, Newborn + Child Health
Seasonal Malaria Chemoprevention Therapy in Children Up To 9 Years of Age: Protocol for a Cluster-Randomized Trial Study.
Toure M, Shaffer JG, Sanogo D, Keita S, Keita M, Kane F, Traore B, Dabitao D, Kone A, Doumbia CO, Keating J, Yukich J, Hansson HH, Barry AE, Diakité M, Alifrangis M, Doumbia S.
Malaria Young People's Health
Evaluation of the use of modelling in resource allocation decisions for HIV and TB.
Bowring AL, Ten Brink D, Martin-Hughes R, Fraser-Hurt N, Cheikh N, Scott N.
Global Infectious Disease Threats HIV + AIDS Tuberculosis (TB)
Patients' experience of accessing hepatitis C treatment through the Myanmar national hepatitis C treatment program: a qualitative evaluation.
Draper B, Yee WL, Bowring A, Naing W, Kyi KP, Htay H, Howell J, Hellard M, Pedrana A.
Hepatitis C Global Infectious Disease Threats